HuGE Literature Finder
Records
1
-
9
| Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients. Journal of medical virology 2016 12 89 (7): 1241-1247. Murakawa Miyako, Asahina Yasuhiro, Kawai-Kitahata Fukiko, Nakagawa Mina, Nitta Sayuri, Otani Satoshi, Nagata Hiroko, Kaneko Shun, Asano Yu, Tsunoda Tomoyuki, Miyoshi Masato, Itsui Yasuhiro, Azuma Seishin, Kakinuma Sei, Tanaka Yasuhito, Iijima Sayuki, Tsuchiya Kaoru, Izumi Namiki, Tohda Shuji, Watanabe Mamo |
| The Impact of IL28B Genotype and Liver Fibrosis on the Hepatic Expression of IP10, IFI27, ISG15, and MX1 and Their Association with Treatment Outcomes in Patients with Chronic Hepatitis C. PloS one 2015 10 (6): e0130899. Domagalski Krzysztof, Paw?owska Ma?gorzata, Kozielewicz Dorota, Dybowska Dorota, Tretyn Andrzej, Halota Waldem |
| Hepatic interferon-gamma-induced protein-10 expression is more strongly associated with liver fibrosis than interleukin-28B single nucleotide polymorphisms in hepatocellular carcinoma resected patients with chronic hepatitis C. Hepatology research : the official journal of the Japan Society of Hepatology 2013 Nov 43 (11): 1139-47. Konishi Hideyuki, Shirabe Ken, Yoshiya Shohei, Ikeda Tetsuo, Ikegami Toru, Yoshizumi Tomoharu, Ikawa-Yoshida Ayae, Motomura Takashi, Fukuhara Takasuke, Maehara Yoshihi |
| Temperature rise after peginterferon alfa-2a injection in patients with chronic hepatitis C is associated with virological response and is modulated by IL28B genotype. Journal of hepatology 2013 Nov 59 (5): 957-63. Han Hwalih, Noureddin Mazen, Witthaus Michael, Park Yoon J, Hoofnagle Jay H, Liang T Jake, Rotman Yar |
| IL28B genotype and the expression of ISGs in normal liver. Liver international : official journal of the International Association for the Study of the Liver 2013 Aug 33 (7): 991-8. Raglow Zoe, Thoma-Perry Carly, Gilroy Richard, Wan Yu-Jui |
| Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response. Hepatology (Baltimore, Md.) 2012 Jan 55 (1): 20-9. Asahina Yasuhiro, Tsuchiya Kaoru, Muraoka Masaru, Tanaka Keisuke, Suzuki Yuichiro, Tamaki Nobuharu, Hoshioka Yoshihide, Yasui Yutaka, Katoh Tomoji, Hosokawa Takanori, Ueda Ken, Nakanishi Hiroyuki, Itakura Jun, Takahashi Yuka, Kurosaki Masayuki, Enomoto Nobuyuki, Nitta Sayuri, Sakamoto Naoya, Izumi Nami |
| Inverse association of IL28B genotype and liver mRNA expression of genes promoting or suppressing antiviral state. Journal of medical virology 2011 Sep 83 (9): 1597-607. Abe Hiromi, Hayes C Nelson, Ochi Hidenori, Tsuge Masataka, Miki Daiki, Hiraga Nobuhiko, Imamura Michio, Takahashi Shoichi, Kubo Michiaki, Nakamura Yusuke, Kamatani Naoyuki, Chayama Kazua |
| IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy. Journal of hepatology 2011 Jun 54 (6): 1094-101. Abe Hiromi, Hayes C Nelson, Ochi Hidenori, Maekawa Toshiro, Tsuge Masataka, Miki Daiki, Mitsui Fukiko, Hiraga Nobuhiko, Imamura Michio, Takahashi Shoichi, Kubo Michiaki, Nakamura Yusuke, Chayama Kazua |
| Dysregulation of IFN system can lead to poor response to pegylated interferon and ribavirin therapy in chronic hepatitis C. PloS one 2011 6 (5): e19799. Onomoto Koji, Morimoto Shiho, Kawaguchi Takahisa, Toyoda Hidenori, Tanaka Masami, Kuroda Masahiko, Uno Kazuko, Kumada Takashi, Matsuda Fumihiko, Shimotohno Kunitada, Fujita Takashi, Murakami Yoshi |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: